Assyro AI
FDA 483 Database

FDA Form 483s Issued in February 2026

Every published Form FDA 483 issued in February 2026, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

6

Published 483s in February 2026

6

Distinct firms

Form 483s issued in February 2026

Staska Pharmaceuticals, IncFDA
FEI
3017473850
Issued
Feb 20, 2026
Establishment
Outsourcing Facility
Location
Nebraska, United States
Eugia Pharma Specialities LimitedFDA
FEI
3011960448
Issued
Feb 27, 2026
Establishment
Sterile Pharmaceutical Manufacturer
Location
India
Global Calcium Private LimitedFDA
FEI
3004094136
Issued
Feb 3, 2026
Establishment
Active Pharmaceutical Ingredient Manufacturer
Location
India
Maiva Pharma Private LimitedFDA
FEI
3014362214
Issued
Feb 20, 2026
Establishment
Sterile Drug Manufacturer
Location
India
Aurobindo Pharma Limited, Unit VIIFDA
FEI
3007373532
Issued
Feb 10, 2026
Establishment
Finished Drug Product Manufacturer
Location
India
Eugia Pharma Specialities LimitedFDA
FEI
3008461619
Issued
Feb 6, 2026
Establishment
Sterile Drug Manufacturer
Location
India

Other months in 2026

Back to the FDA 483 Database